NCT01883440View on ClinicalTrials.gov

Glucose Oxidase as Treatment Against Common Cold

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

September 30, 2013

Conditions
Common Cold
Interventions
DRUG

Glucose oxidase + glucose

Isotone saline + 200U/ml of glucose oxidase + 5% of glucose in a bag on valve nasal spray device

DRUG

Saline+glucose

Placebo arm

Trial Locations (1)

Unknown

Öronmottagningen, Södra Sunderbyn

All Listed Sponsors
lead

Krister Tano

OTHER

NCT01883440 - Glucose Oxidase as Treatment Against Common Cold | Biotech Hunter | Biotech Hunter